IIQ · ASX

Inoviq Ltd (ASX:IIQ)

AU$0.4

 0.0 (0.0%)
ASX:Live
09/05/2025 03:56:13 PM
HALO Ords HALO Consensus Value GROWTH AUS All-Companies
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

IIQ Overview

IIQ Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Neutral

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About IIQ

Website

Inoviq Ltd

Telephone

61.3.9548.7586

Address

23 Normanby Road Notting Hill, Victoria (VIC) 3168

Description

INOVIQ Ltd. is a biotechnology company, which engages in the provision of medical services. It operates through the Australia and United States of America geographical segments. The company was founded on June 30, 1983 and is headquartered in Notting Hill, Australia.

IIQ Price Chart

Key Stats

Market Cap

AU$44.09M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.34 - 0.8

Trade Value (12mth)

AU$16,844.00

1 week

-1.25%

1 month

2.6%

YTD

-25.47%

1 year

-20.2%

All time high

61.12

Key Fundamentals

EPS 3 yr Growth

-50.90%

EBITDA Margin

%

Operating Cashflow

-$4m

Free Cash Flow Return

-21.50%

ROIC

-32.70%

Interest Coverage

-155.80

Quick Ratio

7.10

Other Data

Shares on Issue (Fully Dilluted)

111m

HALO Sector

Healthcare

Next Company Report Date

02-Sep-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

IIQ Announcements

Latest Announcements

Date Announcements

01 May 25

Notification of cessation of securities - IIQ

×

Notification of cessation of securities - IIQ

30 April 25

Quarterly Business Update and Appendix 4C - March 2025

×

Quarterly Business Update and Appendix 4C - March 2025

09 April 25

Notification regarding unquoted securities - IIQ

×

Notification regarding unquoted securities - IIQ

07 April 25

Application for quotation of securities - IIQ

×

Application for quotation of securities - IIQ

04 April 25

Proposed issue of securities - IIQ

×

Proposed issue of securities - IIQ

03 April 25

CAR-exosome therapy webinar presentation slides

×

CAR-exosome therapy webinar presentation slides

01 April 25

Publication of NeuCA15-3 assay data

×

Publication of NeuCA15-3 assay data

31 March 25

IIQ to work with Peter Mac to validate car-exosome therapy

×

IIQ to work with Peter Mac to validate car-exosome therapy

25 March 25

Ceasing to be a substantial holder

×

Ceasing to be a substantial holder

19 March 25

Investor Webinar Presentation

×

Investor Webinar Presentation

17 March 25

INOVIQ appoints Chief Commercial Officer

×

INOVIQ appoints Chief Commercial Officer

11 March 25

Change of Director's Interest Notice

×

Change of Director's Interest Notice

11 March 25

Change of Director's Interest Notice

×

Change of Director's Interest Notice

21 February 25

Appendix 4D and FY25 Half Year Financial Report

×

Appendix 4D and FY25 Half Year Financial Report

10 February 25

INOVIQ establishes Medical and Scientific Advisory Board

×

INOVIQ establishes Medical and Scientific Advisory Board

07 February 25

Notification of cessation of securities - IIQ

×

Notification of cessation of securities - IIQ

31 January 25

Quarterly Business Update and Appendix 4C - December 2024

×

Quarterly Business Update and Appendix 4C - December 2024

16 December 24

Weaponising Exosomes for Breast Cancer treatment

×

Weaponising Exosomes for Breast Cancer treatment

11 December 24

Investor Webinar Presentation

×

Investor Webinar Presentation

05 December 24

Disease Specificity study completed for NeuCA15-3 test

×

Disease Specificity study completed for NeuCA15-3 test

03 December 24

EXO-OC test delivers outstanding performance

×

EXO-OC test delivers outstanding performance

02 December 24

Change of Director's Interest Notice

×

Change of Director's Interest Notice

02 December 24

AGM Replay

×

AGM Replay

29 November 24

Notification regarding unquoted securities - IIQ

×

Notification regarding unquoted securities - IIQ

28 November 24

AGM CEO Presentation

×

AGM CEO Presentation

IIQ Fundamentals

Per Share Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.20 -0.10 -0.07 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.20 -0.10 -0.07 Lock Lock Lock
     Growth % Lock Lock Lock Lock -38.8 51.3 27.3 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.05 -0.08 -0.05 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.07 -0.08 -0.05 Lock Lock Lock
     Growth % Lock Lock Lock Lock 11.5 -44.1 40.5 Lock Lock Lock
     Yield % Lock Lock Lock Lock -17.9 -9.3 -8.7 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 0 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.31 0.21 0.22 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.18 0.10 0.11 Lock Lock Lock
     Growth % Lock Lock Lock Lock 397.0 -46.1 14.7 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 91 92 92 Lock Lock Lock
Basic m Lock Lock Lock Lock 91 92 92 Lock Lock Lock

Financial Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Income Statement
Sales $m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
     Growth % Lock Lock Lock Lock -40.9 43.9 34.4 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 7 9 7 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -2 -1 -1 Lock Lock Lock
     Growth % Lock Lock Lock Lock 45.4 44.7 4.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock -679.8 -261.2 -185.0 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 780 361 285 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -7 -9 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -10.5 -28.2 29.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -2,542.3 -2,265.9 -1,187.2 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 2 1 1 Lock Lock Lock
EBIT $m Lock Lock Lock Lock -9 -10 -8 Lock Lock Lock
     Growth % Lock Lock Lock Lock -25.5 -14.0 25.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock -3,301.7 -2,615.9 -1,457.0 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -22 -10 -8 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -3 -1 -1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock -18 -9 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -63.2 50.7 26.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock -6,575.0 -2,252.5 -1,224.8 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -6 -7 -4 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 17 0 6 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -6 -7 -4 Lock Lock Lock
     Growth % Lock Lock Lock Lock -11.7 -15.0 38.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock -22.9 -18.3 -8.4 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 15 8 9 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 31 22 22 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 1 0 0 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -14 -7 -9 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 2 2 2 Lock Lock Lock
Equity $m Lock Lock Lock Lock 28 20 20 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 29 20 20 Lock Lock Lock
     Growth % Lock Lock Lock Lock -3.5 -30.9 0.8 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -59.1 -41.7 -30.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -64.3 -45.7 -32.8 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -30.7 -42.0 -38.2 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -61.8 -36.7 -32.7 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -20.6 -28.7 -21.5 Lock Lock Lock

Ratios Records

Historical data

Forecast data

AUD 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
Leverage
Interest Cover X Lock Lock Lock Lock -85.8 -151.6 -155.8 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 2.0 0.8 1.4 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -50.9 -36.1 -43.5 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 9.7 6.2 7.1 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 9.7 6.2 7.1 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 88.1 83.1 85.0 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -337.5 -462.8 -281.7 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.3 0.3 0.4 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 70.8 92.1 85.6 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.1 0.1 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 368.5 117.3 117.1 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -7,794.5 -2,527.4 -1,416.7 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -70.1 -46.8 -34.9 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -59.1 -41.7 -30.2 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.1 1.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -64.3 -45.7 -32.8 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -64.3 -45.7 -32.8 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 5.2 4.0 4.3 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 1,269.7 1,328.6 841.4 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 1,274.9 1,332.6 845.7 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 139.6 188.1 130.9 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 1,135.3 1,144.5 714.8 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

N/A

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

IIQ Shortsell

Frequently Asked Questions

The current share price of Inoviq Ltd (IIQ:ASX) is AU$0.4.
The 52-week high share price for Inoviq Ltd (IIQ:ASX) is AU$0.80.
The 52-week low share price for Inoviq Ltd (IIQ:ASX)? is AU$0.34.
Inoviq Ltd (IIQ:ASX) does not pay a dividend.
Inoviq Ltd (IIQ:ASX) does not pay a dividend.
Inoviq Ltd (IIQ:ASX) has a franking level of 0.0%.
Inoviq Ltd (IIQ:ASX) is classified in the Healthcare.
The current P/E ratio for Inoviq Ltd (IIQ:ASX) is .
logo
Login
Company
Company
Important

Get the latest insights and hot tips delivered right to your inbox

App Store Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.